Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
5
×
life sciences
medicaid
5
×
national blog main
national top stories
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
johnson & johnson
national
amgen
biotech
brexanolone
eli lilly
gene therapy
medicare
novartis
sanofi
spinal muscular atrophy
What
drug
roundup
therapy
administration
age
agency
ahead
aimmune
allergy
alzheimer’s
ambien
american
angry
annual
anti
approval
approved
asco
attendees
attention
awarded
benefited
bigger
biggest
bio
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
come
community’s
congress
days
deal
democrats
despite
Language
unset
Current search:
medicaid
×
fda
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More